These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 12687611)
1. Use of serological proteomic methods to find biomarkers associated with breast cancer. Rui Z; Jian-Guo J; Yuan-Peng T; Hai P; Bing-Gen R Proteomics; 2003 Apr; 3(4):433-9. PubMed ID: 12687611 [TBL] [Abstract][Full Text] [Related]
2. [Detection and clinical significance of serum proteomic patterns of breast cancers by surface enhanced laser desorption/ionization time of flight mass spectrometry]. Zhang GQ; Du J; Pang D Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):204-7. PubMed ID: 16875606 [TBL] [Abstract][Full Text] [Related]
3. The evolving role of proteomics in the early detection of breast cancer. Pawlik TM; Kuerer HM Int J Fertil Womens Med; 2005; 50(5 Pt 1):212-6. PubMed ID: 16468471 [TBL] [Abstract][Full Text] [Related]
4. Proteomic analysis in human breast cancer: identification of a characteristic protein expression profile of malignant breast epithelium. Hudelist G; Singer CF; Pischinger KI; Kaserer K; Manavi M; Kubista E; Czerwenka KF Proteomics; 2006 Mar; 6(6):1989-2002. PubMed ID: 16470630 [TBL] [Abstract][Full Text] [Related]
5. Proteomic tracking of serum protein isoforms as screening biomarkers of ovarian cancer. Ahmed N; Oliva KT; Barker G; Hoffmann P; Reeve S; Smith IA; Quinn MA; Rice GE Proteomics; 2005 Nov; 5(17):4625-36. PubMed ID: 16220531 [TBL] [Abstract][Full Text] [Related]
6. [Diagnostic application of serum protein pattern and artificial neural network software in breast cancer]. Hu Y; Zhang SZ; Yu JK; Liu J; Zheng S; Hu X Ai Zheng; 2005 Jan; 24(1):67-71. PubMed ID: 15642203 [TBL] [Abstract][Full Text] [Related]
7. Identification of potential markers for the detection of pancreatic cancer through comparative serum protein expression profiling. Ehmann M; Felix K; Hartmann D; Schnölzer M; Nees M; Vorderwülbecke S; Bogumil R; Büchler MW; Friess H Pancreas; 2007 Mar; 34(2):205-14. PubMed ID: 17312459 [TBL] [Abstract][Full Text] [Related]
8. Proteomic analysis of nipple aspirate fluid from women with early-stage breast cancer using isotope-coded affinity tags and tandem mass spectrometry reveals differential expression of vitamin D binding protein. Pawlik TM; Hawke DH; Liu Y; Krishnamurthy S; Fritsche H; Hunt KK; Kuerer HM BMC Cancer; 2006 Mar; 6():68. PubMed ID: 16542425 [TBL] [Abstract][Full Text] [Related]
9. Proteomics for the identification of new prostate cancer biomarkers. Ornstein DK; Tyson DR Urol Oncol; 2006; 24(3):231-6. PubMed ID: 16678055 [TBL] [Abstract][Full Text] [Related]
10. Application of serum SELDI proteomic patterns in diagnosis of lung cancer. Yang SY; Xiao XY; Zhang WG; Zhang LJ; Zhang W; Zhou B; Chen G; He DC BMC Cancer; 2005 Jul; 5():83. PubMed ID: 16029516 [TBL] [Abstract][Full Text] [Related]
11. [Proteomics and breast cancer]. Mathelin C; Tomasetto C; Cromer A; Rio MC Gynecol Obstet Fertil; 2006 Dec; 34(12):1161-9. PubMed ID: 17123853 [TBL] [Abstract][Full Text] [Related]
12. Clinical proteomics in breast cancer: a review. Gast MC; Schellens JH; Beijnen JH Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706 [TBL] [Abstract][Full Text] [Related]
13. Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry. Yu KH; Rustgi AK; Blair IA J Proteome Res; 2005; 4(5):1742-51. PubMed ID: 16212428 [TBL] [Abstract][Full Text] [Related]
14. [Clinical significance of serum proteomic patterns in diagnosis of breast cancer]. Liu DH; Zhang LM; Feng WY Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):770-1. PubMed ID: 17366791 [No Abstract] [Full Text] [Related]
15. Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry. Han KQ; Huang G; Gao CF; Wang XL; Ma B; Sun LQ; Wei ZJ Am J Clin Oncol; 2008 Apr; 31(2):133-9. PubMed ID: 18391596 [TBL] [Abstract][Full Text] [Related]
16. Novel breast cancer biomarkers identified by integrative proteomic and gene expression mapping. Ou K; Yu K; Kesuma D; Hooi M; Huang N; Chen W; Lee SY; Goh XP; Tan LK; Liu J; Soon SY; Bin Abdul Rashid S; Putti TC; Jikuya H; Ichikawa T; Nishimura O; Salto-Tellez M; Tan P J Proteome Res; 2008 Apr; 7(4):1518-28. PubMed ID: 18318472 [TBL] [Abstract][Full Text] [Related]
18. [Preliminary study on proteomic patterns in hepatic tissue to identify HBV related hepatocellular carcinoma]. Long YZ; Fan XG; Li N; Huang YK Zhonghua Gan Zang Bing Za Zhi; 2004 Apr; 12(4):231-3. PubMed ID: 15099477 [TBL] [Abstract][Full Text] [Related]
19. Autoantibody to tumor antigen, alpha 2-HS glycoprotein: a novel biomarker of breast cancer screening and diagnosis. Yi JK; Chang JW; Han W; Lee JW; Ko E; Kim DH; Bae JY; Yu J; Lee C; Yu MH; Noh DY Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1357-64. PubMed ID: 19423516 [TBL] [Abstract][Full Text] [Related]
20. Secretomic and proteomic analysis of potential breast cancer markers by two-dimensional differential gel electrophoresis. Lai TC; Chou HC; Chen YW; Lee TR; Chan HT; Shen HH; Lee WT; Lin ST; Lu YC; Wu CL; Chan HL J Proteome Res; 2010 Mar; 9(3):1302-22. PubMed ID: 20052998 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]